Two multi-year collaborative agreements were recently established by Amgen and the University of Texas MD Anderson Cancer Center…
Articles by Inês Martins, PhD
Most U.S. residents are unaware there are shortages in the availability of cancer drugs, such as those for multiple…
Janssen has decided to discontinue a Phase 1 trial assessing Darzalex (daratumumab) in combination with JNJ-63723283 — an anti-PD-1 antibody…
Researchers in Canada are studying how to reduce the risks associated with the treatment of multiple myeloma by improving…
Stand Up to Cancer (SU2C) recently awarded $10 million to a SU2C Dream Team that wants to move the…
A Phase 1 clinical trial testing therapy candidate STRO-001 for lymphoma and myeloma has started treating its first patients,…
As part of its $15 million Immunotherapy Initiative, the Multiple Myeloma Research Foundation (MMRF) recently awarded $7 million in…
AbbVie and the International Myeloma Foundation are collaborating to study the role of a genetic mutation — the t(11;14) translocation…
To raise awareness of multiple myeloma and funding for research, 18 patients, caregivers, and healthcare professionals have embarked on a…
As UT Southwestern and Celgene Corporation join efforts to launch a new clinical trial to evaluate a…